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TIMP-3 mRNA expression is regionally increased in
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adenocarcinoma
DG Powe', JL Brough', GI Carter1, EM Bailey', WG Stetler-Stevenson2, DR Turner1 and RE Hewitt',2
'Department of Histopathology, Queen's Medical Centre, Nottingham NG7 2UH, UK; 2Laboratory of Pathology, National Cancer Institute, National Institutes of
Health, Bethesda MD 20892-1500, USA
Summary In this study, we report on the distribution of tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) mRNA expression in human
normal colorectal mucosa, adenomas and adenocarcinomas. Northern blot analysis showed five TIMP-3 mRNA transcripts to be present in
normal mucosal epithelium and in moderately and poorly differentiated carcinoma. Adenomas and well-differentiated carcinomas were not
examined in this part of the investigation. In situ hybridization studies showed no detectable TIMP-3 mRNA in normal and adenomatous
tissue. In contrast, TIMP-3 mRNA is localized to stromal fibroblast-like cells in colorectal carcinomas, with an increased incidence in
moderately and poorly differentiated groups compared with well-differentiated carcinomas. Expression in both the moderately and the poorly
differentiated tumour groups was strongest at the tumour invasive edge; none of the poorly differentiated carcinomas showed mRNA
expression in regions ahead of the invasive edge, compared with 3 of 12 of the moderate group. To our knowledge, this is the first detailed
report on the regional localization of TIMP-3 mRNA in colorectal tumours. We suggest that the lack of TIMP-3 mRNA expression in host
stromal tissues ahead of poorly differentiated carcinomas may contribute to their increased invasiveness.
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Tumour invasion is amultistep process involving disruption ofthe
epithelial basement membrane (EBM) and remodelling of the
connective tissue matrix (Liotta and Stetler-Stevenson, 1991). A
growing body of evidence supports the involvement of matrix
metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in
tumour invasion (Stetler-Stevenson, 1990; Hewitt et al, 1991;
Poulsom et al, 1992). Three human TIMP forms have been
described; TIMP-1 is a 28.5-kDa glycoprotein that inhibits
interstitial collagenase (Docherty et al, 1985). TIMP-2 shares
approximately 40% homology with TIMP-1 and inhibits type IV
collagenase (Stetler-Stevenson et al, 1989). More recently, a third
member, TIMP-3, has been described (Pavloffet al, 1992), having
a predicted Mr of 21.6 kDa (Uria et al, 1995) and is localized to
chromosome 22 (Apte et al, 1994). TIMP-3 notably shares a high
nucleotide homology (82.4%) with chicken inhibitor of metallo-
proteinase-3 (ChIMP3) (Pavloff et al, 1992) and shares a 25%
amino acid homology with TIMP-1 and TIMP-2 (Apte et al,
1995). Inhibitory enzyme activities on the substrates human gelati-
nases A and B, collagenase-I and stromelysin-I are remarkably
similar for TIMP-1 and TIMP-3 (Apte et al, 1995). Northern blot
analysis has localized TIMP-3 mRNA in human breast tumours,
placenta, uterus, heart, kidney, lung, pancreas, skeletal muscle and
brain, but conflicting reports exist for its occurrence in liver (Apte
et al, 1994; Uria et al, 1995). Apte et al (1994) propose that TIMP-
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Previously, we demonstrated an association ofTIMP-1 with the
progression of colorectal tumours from adenomas to invasive
adenocarcinoma (Hewitt et al, 1991); normal mucosa showed
weak immunostaining while the adenomas showed an absence of
TIMP-1 staining compared with the carcinomas. Davies et al
(1993a) found TIMP-1 expression to be correlated to the more
aggressive tumour phenotype in bladder cancers, while Zeng et al
(1995a) identified increased TIMP-1 expression in colorectal
carcinomas with metastases.
For the present study, we used in situ hybridization (ISH) and
Northern blot analysis to investigate the cellular origin ofTIMP-3
mRNA expression in normal mucosa, benign adenomas and
adenocarcinoma ofthe colorectum. We also examinedthe relation-
ship between the level ofTIMP-3 expression and tumour grade.
MATERIALS AND METHODS
Tissue samples
Fresh, surgically resected bowel specimens received in the
Histopathology Department, Queen's Medical Centre, were
dissected with minimal delay to provide samples of normal
mucosa, adenomaandadenocarcinoma. The adenocarcinoma were
taken to include viable, non-necrotic tissue containing an invasive
edge with adjacent normal mucosa. Tissue samples were divided
into two portions: one piece was fixed in buffered 4%
paraformaldehyde for 24 h before paraffin wax processing. The
other sample was snap frozen in isopentane precooled in liquid
nitrogen and stored at -70°C until required. Normal mucosa was
dissected from uninvolved resection margins and treated similarly
to the tumour samples. RNAase-free reagents and conditions were
maintained.
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Figure 1 This schematic diagram shows how the tumour sections were
divided into regions for recording the TIMP-3 ISH results. The invasive edge
(I) extended from the limit of visible tumour invasion to the edge of the tumour
centre (TC), measuring two x25 objective lens fields away. The adjacent host
stroma (HA) region had the invasive edge as one border and extended two
x25 objective lens fields away to the border of the distant host stroma (HD)
Northern blotting
Total RNA was isolated from human colorectal tissue samples
using the Trizol method (Life Technologies, Paisley, UK). Purity
and yield of RNA were determined spectrophotometrically. For
Northern blotting studies, 7 gg ofeach RNA sample was electrop-
horesed through 1% agarose-formaldehyde gel and blotted onto
Hybond-N membrane (Amersham, Bucks, UK). Northern blot
hybridization and autoradiography were as previously described
with final stringency washes in 0.1 x SSPE/0.1% sodium dodecyl
sulphate (SDS) (Hewitt et al, 1993).
Probes
The human TIMP-3 plasmid was a gift from Dr J Uria and
consisted of a 1.1-kb BamHIIXhoI cDNA from a previously
described plasmid (Uria et al, 1995) ligated into pBluescript SKII
(Stratagene). Antisense cRNA probe was prepared by transcribing
BamHI linearized plasmid with T7 polymerase (Promega,
Southampton, UK); sense cRNA probe was prepared by tran-
scribingXhoI linearized plasmid withT3 polymerase. Probes were
labelled with [32P]CTP (Amersham, Bucks, UK) for Northern
hybridization and [35S]CTP (Du Pont, Herts, UK) for ISH. Probes
used for ISH were hydrolysed to approximately 0.2 kb.
TIMP-3 in situ hybridization
Paraffin wax-embedded sections (5 jim thick) were dewaxed in
xylene and rehydrated to RNAase-free water. Using RNAase-free
conditions throughout, the sections were treated according to a
method based on that of Senior et al (1988). Sections were
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Figure 2 Five transcripts were detected for TIMP-3 mRNA in colorectal normal
mucosa (n) and adenocarcinoma (t); the strongest expression was seen in the
5.0-kb transcript. a = 5.0 kb, b = 2.1 kb, c = 1.6 kb, d = 1.4 kb, e = 1.0 kb
hybridized with a RNA probe at an activity equivalent to 1 x 106
c.p.m. per section. Subsequently, the sections were given
stringency washes that included three 20-min washes in 60%
formamide/4 x standard saline citrate (SSC) at 50°C, a wash in
2xSSC at 50°C and incubation in 100 jg ml-1 RNAase A (Sigma,
Dorset, UK) for 30 min at37°C. Sections were washedin 0.lxSSC
for 20 min at 37°C and then dehydrated in ethanol. Probe was
detected using LM-1 autoradiographic emulsion (Amersham) with
exposure for up to 24 days on replicate sections; sections were
counterstained with haematoxylin and eosin.
Following in-situ hybridization, sections were subjectively
assessed using bright- and dark-field illumination under low- and
high-power magnifications. Each whole section was scanned for
hybridization signal using low-power magnification (x1O objective)
with dark-field illumination; areas showing increased signal were
further investigated using high magnification (x40 objective) with
bright-field illumination. Typically, 950 and 1250 cells were
viewed per high-power field for stroma or stroma/neoplastic
epithelium respectively. Cells showing more than 25 silver grains
compared with the sense (negative control) were considered to
show specific signal; replicate sections treated with the antisense
and sense (negative control) probes were compared. The carci-
noma sections were divided into the following regions and the
presence of hybridization signal recorded: tumour centre (TC),
tumour periphery (TP), neighbouring adjacent host (HA) stroma
and distant host (HD) stroma (Figure 1).
RESULTS
Northern blot analysis
Twelve cases of paired tumour and uninvolved mucosa were
analysed comprising nine moderately and three poorly differenti-
ated adenocarcinomas. Following hybridization and exposure, the
autoradiographs showed five bands on development (Figure 2);
comparison with RNA standards estimated them to be 5.0 kb,
2.1 kb, 1.6 kb, 1.4 kb and 1.0 kb in size.
The optical densities (ODs) of the autoradiograph bands were
determined using a Seescan (Cambridge, UK) image analyser and
the tumour-normal ratios calculated (data not shown).
The 5.0-kb transcript showed a higher level ofexpression than
the four smaller transcripts in 7 of 12 paired samples. TIMP-3
expression was increased in five ofnine moderately differentiated
tumours compared with the corresponding normal mucosa, with
up to a threefold increase (range 1.07-3.2). In contrast, the
remaining four moderately differentiated tumours showed
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Table 1 In situ hybridization results for TIMP-3 mRNA in well (WD)-, moderately (MD) and poorly (PD) differentiated colorectal
adenocarcinomas.
Case number Tumour grade Cell type Signal localization
TC I H Adj H Dist
1 WD NA -
2 WD NA - - - -
3 WD NA - - - -
4 WD F - Yes
5 WD NA - - - -
6 MD NA - - - -
7 MD NA - - - -
8 MD F Yes Yes Yes Yes
9 MD NA - - - -
10 MD F - Yes
11 MD F Yes Yes Yes
12 MD NA - - - -
13 MD F - Yes -
14 MD F Yes Yes - Yes
15 MD F - Yes -
16 MD F - Yes -
17 MD NA - - - -
18 PD F Yes Yes - -
19 PD F Yes Yes - -
20 PD F - Yes - -
21 PD F Yes Yes - -
22 PD F - Yes - -
23 PD F - Yes - -
24 PD NA - - - -
F, fibroblast-like cell shows signal; NA, not applicable; TC, tumour centre; I, invasive edge; H Adj,
host distant stroma; -, no signal detected.
increased expression in the matched normal samples (range
1.02-1.77). Slight increases in TIMP-3 expression occurred in two
ofthree poorly differentiated tumours (range 1.15-1.19).
The four smallertranscripts ofTIMP-3 (2.1 kb, 1.6kb, 1.4kb and
1.0 kb) showed increased expression in the normal mucosa samples
(range 1.02-3.35) in all but two cases; one ofthe moderately differ-
entiated tumours showed increased expression in all five transcripts
(range 2.65-3.5), while a second tumour ofthe same grade showed
increased expression in the 1.0-kb and 1.4-kb transcripts.
In situ hybridization
A positive cellular ISH signal was determined by increased silver
grain frequency per cell and by comparison of the antisense and
sense (negative control) probed sections.
All five samples of uninvolved normal mucosa obtained from
the surgical resection margins were negative for TIMP-3 mRNA.
Additionally, many of the adenocarcinoma samples contained
normal mucosa adjacent to the neoplastic epithelium and none
showed specific signal. Also, none of the six adenoma samples
investigated showed specific hybridization signal with the TIMP-3
antisense probe.
An increased number of silver grains were seen localized to
stromal cells in only one offive well-differentiated bowel samples
probed with the TIMP-3 antisense probe (Table 1). Many of the
cells showing signal were spindle shaped or had large open nuclei
and were most probably fibroblasts, though the involvement of
macrophages or endothelial cells can not be entirely discounted.
Messenger RNA expression was localized focally at the tumour
invasive edge.
host adjacent stroma; H Dist,
In marked contrast, 7 of 12 cases of the moderately differenti-
ated tumours showed TIMP-3 expression (Table 1) localized to
stromal cells (Figure 3A, B). All of the positive cases showed
localization at the invasive edge, with the distribution in the adja-
cent host stroma being the second most frequent site; signal in
distant host stroma was seen in some cases. The poorly differenti-
ated adenocarcinomas showed TIMP-3 mRNA expression in
fibroblast-like cells at the invasive edge of six out of seven cases
examined (Table 1; Figure 3C); three ofthese cases showed signal
in stromal cells in the tumour centre. None of the cases analysed
showed signal in stromal cells ahead of the invasive edge and,
generally, the signal was weaker than that seen for the moderately
differentiated group ofcarcinomas.
Replicate sections probed with the labelled-sense probe (nega-
tive control) showed background levels of signal only, with grain
distributed over all cell types (Figure 3D).
DISCUSSION
MMPs and TIMPs are involved in normal developmental and
pathological processes (Nomura et al, 1989; Firestein and Paine,
1992). The study of the distribution and biological mechanism of
action ofMMPs and TIMPs is proving to be oftherapeutic impor-
tance (Davies et al, 1993b). In the current study, we present a
detailed description of the regional localization for TIMP-3
mRNA in normal mucosa, adenomas and in well-, moderately and
poorly differentiated adenocarcinomas ofthe bowel.
Weidentified five transcripts forTIMP-3 (5.0 kb, 2.1 kb, 1.6kb,
1.4 kb and 1.0 kb) using Northem analysis, which is in agreement
with the number identified by Uria et al (1995) in a study ofbreast





Figure 3 (A) A moderately differentiated colonic adenocarcinoma probed for TIMP-3 mRNA. Hybridization signal (arrowed) is distributed in the stroma
surrounding the neoplastic glands (N) at the tumour invasive edge. B (Detail of A) and C (poorly differentiated adenocarcinoma) show that TIMP-3 mRNA is
localized to round and spindle-shaped stromal cells (arrowed). (D) A replicate section of B treated with the TIMP-3 sense (negative control) probe showing
background signal only. Counterstain: haematoxylin and eosin. Bar = 25 gm
tumour, placenta and uterus. However, in the latter study, the tran-
scripts were estimated to be 5.0kb, 2.7 kb, 2.4 kb, 1.6kb and 1.1 kb.
Apte et al (1994) identified only three TIMP-3 transcripts
(5.5 kb, 2.8 kb and 2.4 kb) in a comprehensive range of tissues,
including kidney, lung and pancreas, but the 2.8-kb transcript was
absent from brain.
In normal colonic mucosa, we identified predominanfly elevated
TIMP-3 mRNA expression in four of the five transcripts (2.1 kb,
1.6 kb, 1.4 kb and 1.0 kb). In contrast, 7 of 12 tumour cases showed
increased expression ofthelargest (5.0kb) transcript and, generally,
this transcript gave a stronger band on autoradiography than the
smaller ones, suggesting a higher abundance. Interestingly, in
breast tumours, uterus and placenta, the 2.4-kb transcript appears
to be overexpressed (Uria et al, 1995). Despite using the same
probe as Uria et al (1995), the differences in transcript size and
relative level of expression reported here may prove to be impor-
tant. Uria et al (1995) suggest a number ofexplanations, including
alternative polyadenylation sites, variable extension of the 5'
flanking region or the existence of additional genes possessing
similar sequences to those ofTIMP-3. Byrne et al (1995) proposed
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that cell and tissue factors are at least responsible for controlling
the selection ofthe polyadenylation sites. Our findings add further
to the evidence that tissue-specific factors influence the pattern of
expression of the different TIMP-3 transcripts.
Northern analysis showed TIMP-3 mRNA expression in normal
mucosa. However, using ISH, specific TIMP-3 mRNA expression
was not detected in either normal colorectal mucosa or adenomas.
An absence ofdiscernible signal in the ISH-probed normal mucosa
may be due to differences in signal to noise ratios between the two
techniques. These findings are consistent with those of Zeng et al
(1995a) who found that normal colonic mucosa did not express
TIMP-1 mRNA by ISH. Our findings suggest a diffuse distribution
of low level TIMP-3 expression in normal mucosa, which is
detectable by Northern blotting but below the sensitivity ofthe ISH
technique used. In situations of low mRNA abundance, ISH signal
differences between antisense- and sense-probed sections may be
difficult to interpret because of the annealing of vector sequences
of sense RNA probes, generated using the pBluescript vector,
annealing to human 28s rRNA (Witkiewicz et al, 1993).
We demonstrated stromal TIMP-3 mRNA expression in round
and spindle-shaped cells with a fibroblast-like appearance, but the
possibility that these cells were macrophages or endothelial cells
cannot be excluded. TIMPs have been shown to be expressed in
endothelial cells during angiogenesis (Cornelius et al, 1995).
TIMP-3 expression was seen in moderately and poorly differenti-
ated colorectal carcinomas with localization at the invasive edge
being a feature of both groups. However, it is interesting and
perhaps significant to note the localizational differences between
the two tumour grades. Whereas strong expression is seen
throughout the tumour and in adjacent and distant host stroma of
moderately differentiated cancers, poorly differentiated carci-
nomas failed to show TIMP-3 localization in the stroma ahead of
the invasive edge. Overall, a weaker ISH signal was seen with the
poorly differentiated carcinomas, suggesting reduced levels of
expression. Our findings corroborate those of Byrne et al (1995)
who identified that the strongest TIMP-3 ISH signal in breast
carcinomas occurred in fibroblasts closest to the neoplastic cells.
Tumour-secreted factors acting over a short range may account for
the occurrence of activated fibroblasts in this region. Previous
immunochemical studies have localized a MMP-inducing factor
to the peripheral tumour cells of transitional bladder cancers
(Muraoka et al, 1993); TIMP-1 has also been associated with
MMP inducement (Clark et al, 1994).
In vivo, MMPs and TIMPs may be independently expressed,
such is the case with TIMP-1 and MMP-9 (Zeng and Guillem,
1995). The TIMP family of molecules have a highly conserved
N-terminal structure with TIMP-3 and TIMP-1 sharing a 72%
amino acid homology. Similarities in the N-tenminal region prob-
ably account for the similar pattern of inhibition seen (Apte et al,
1995). Currently, the precise MMP substrates for TIMP-3 are
unknown but if TIMP-3 shares similar inhibiting properties to
TIMP-2, it may be involved in regulating EBM breakdown.
Previous studies have demonstrated the localized distribution and
temporal occurrence of MMPs and TIMPs. Matrilysin (MMP-7)
has been implicated in basement membrane degradation and
occurs in increased expression in the highly invasive colonic carci-
nomas (Newell et al, 1994). MMP-2 (synthetic gelatinase A)
mRNA expression has been localized in fibroblasts at the invasive
edge ofcolorectal cancer using ISH (Poulsom et al, 1992; Pyke et
al, 1993), and active MMP-2 enzyme has been zymographically
demonstrated to be correlated to increasing tumour grade in
bladder tumours (Davies et al, 1993a).
Our findings support the proposal of tumour invasion being a
result of an MMP-TIMP imbalance (Stetler-Stevenson, 1990).
The importance of the regional localization of TIMP-3 mRNA
expression, using the in situ hybridization technique, is seen in
considering the moderately and poorly differentiated tumour
groups. An absence of TIMP-3 ISH signal in the stroma ahead of
the invasive edge was seen in the more aggressive poorly differen-
tiated carcinomas. In these regions, unopposed MMP activity
may account for the increased frequency of metastasis seen in
this group of tumours. The MMP-inhibitory function of TIMP-1
was demonstrated in an in vitro study by Khokha et al (1989) in
which TIMP antisense RNA-treated Swiss 3T3 fibroblasts had
reduced TIMP-1 levels, resulting in increased tumour growth and
metastasis. The increased TIMP-3 expression seen at the invasive
edge of moderately and poorly differentiated carcinomas in the
current study is probably explained by the net balance of
MMP-TIMP, with MMP expression increased relative to that of
the inhibitor. The decline in the TIMP-3 mRNA expression (for
moderately and poorly differentiated tumours) with increasing
distance from the tumour mass is consistent with our previous
immunochemical study in which TIMP-1 staining was seen to be
reduced with increasing distance from the tumour invasive edge
(Hewitt et al, 1991).
Lack of detectable mRNA expression in the well-differentiated
tumour group may be due to reduced TIMP-3 (and its MMP
substrate) involvement in the early events of invasion, or differen-
tial expression of TIMP-3 may occur as the tumour loses its
differentiation. Northern analysis was not performed on well-
differentiated tumours in this study.
The localization of TIMP-3-expressing stromal cells is broadly
similar to that forTIMP-1 in moderately differentiated carcinomas
(Powe et al, in preparation), but the TIMP-3 mRNA expression
was decreased compared with TIMP-1 in poorly differentiated
cancers. Both inhibitors have been shown to have similar activities
on the same substrates, including human gelatinase A and B,
collagenase-1 and stromelysin-I (Apte et al, 1995). In addition to
their inhibition properties, TIMP-1 and TIMP-2 also have growth-
stimulating properties (Docherty et al, 1985; Stetler-Stevenson
et al, 1989) and TIMP-1 has been shown to increase fibroblast
collagenase production (Clark et al, 1994). In the current study,
maximal TIMP-3 expression occurred in the stroma associated
with the tumourinvasive edge ofthe moderately and poorly differ-
entiated colorectal adenocarcinomas. Tumour growth-promoting
properties of TIMPs may account for the increased invasiveness
associated with this group oftumours and for the findings ofFong
et al (1996). In non-small-cell lung carcinomas, Fong et al (1996)
showed an association between high TIMP-1 expression and poor
prognosis.
In summary, TIMP-3 expression is increased at the invasive
edge of moderately and poorly differentiated adenocarcinomas
compared with well-differentiated carcinomas, adenomas and
normal mucosa. In addition, both tumour groups show markedly
reduced expression in fibroblast-like cells ahead of the tumour
invasive edge but important regional differences also exist
between the two groups. Deficient TIMP-3 expression ahead of
the invasive edge of poorly differentiated tumours may be
associated with increased tumour invasion and metastasis due to
unopposed MMP activity.
British Journal ofCancer(1997) 75(11), 1678-1683 0 CancerResearch Campaign 1997TIMP-3 mRNA in colorectal adenocarcinoma 1683
ACKNOWLEDGEMENTS
The authors thank Miss Anne Kane for her skilled photographic
assistance. This project was funded by a grant from the Trent
Regional Health Authority and Departmental funds.
REFERENCES
Apte SS, Mattei MG and Olsen BR (1994) Cloning ofthe cDNA encoding human
tissue inhibitor ofmetalloproteinase-3 (TIMP-3) and mapping ofthe TIMP-3
gene to chromosome 22. Genomics 19: 86-90
Apte SS, Olsen BR and Murphy G (1995) The gene structure oftissue inhibitor of
metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct
TIMP gene family. JBiol Chem 270: 14313-14318
Byrne JA, Tomasetto C, Rouyer N, Bellocq JP, Rio MC and Basset P (1995) The
tissue inhibitor ofmetalloproteinases-3 gene in breast carcinoma: identification
ofmultiple polyadenylation sites and a stromal pattern ofexpression. MolMed
4: 418-427
Clark IM, Powell LK and Cawston TE (1994) Tissue inhibitor ofmetalloproteinases
(TIMP-1) stimulates the secretion ofcollagenase from human skin fibroblasts.
Biochem Biophys Res Consm 203: 874-880
Cornelius LA, Nehring LC, Roby JD, Parks WC and Welgus HG (1995) Human
dermal microvascular matrix metalloproteinases in response to angiogenic
factors and migration. JInvestDermatol 105: 170-176
Davies B, Waxman J, HarpretW, Abel P, Williams G, Krausz T, Nezl D, Thomas D,
Hanby A and Balkwill F (1993a) Levels ofmatrix metalloproteinases in
bladder cancercorrelate with tumour grade and invasion. Cancer Res 53: 1-5
Davies B, Brown PD, EastN, Crimmin MJ and Balkwill F (1993b) A synthetic matrix
metalloproteinase inhibitor decreases tumourburden andprolongs survival of
mice bearing human ovarian carcinoma xenografts. CancerRes 53: 2087-2091
Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR, Murphy G
and Reynolds JJ (1985) Sequence ofhuman tissue inhibitor of
metalloproteinases and its identity to erythroid-potentiating activity. Nature
318: 66-69
Firestein GS and Paine MM (1992) Stromelysin and tissue inhibitor of
metalloproteinases gene expression in rheumatoid arthritis synovium. Am J
Pathol 140: 1309-1314
Fong KW, Kida Y, Zimmerman PV and Smith PJ (1996) TIMP-1 and adverse
prognosis in non-small cell lung cancer. Clin Cancer Res 2: 1369-1372
Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE and Turner DR (1991)
Distribution ofcollagenase and tissue inhibitors ofmetalloproteinases (TIMP)
in colorectal tumours. IntJ Cancer 49: 666-672
Hewitt RE, Powe DG, Carter GI and Turner DR (1993) Desmoplasia and its
relevance to colorectal tumour invasion. IntJ Cancer 53: 62-69
Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G and Denhardt
DT (1989) Antisense RNA-induced reduction in murine TIMP levels confers
oncogenicity on Swiss 3T3 cells. Science 243: 947-950
Liotta LA and Stetler-Stevenson WG (1991) Tumour invasion and metastasis: an
imbalance ofpositive and negative regulation. Cancer Res 51: 5054s-5059
Muraoka K, Nabeshima K, Murayama T, Biswas C and Koono M (1993) Enhanced
expression ofatumour-cell-derived collagenase stimulatory factor in urothelial
carcinoma: its usefulness as a tumour marker forbladder cancers. IntJ Cancer
55: 19-26
Newell KJ, Witty JP, Rodgers WH and Matrisian LM (1994) Expression and
localisation ofmatrix-degrading metalloproteinases during colorectal
tumorigenesis. Mol Carcinogen 10: 199-206
Nomura S, Hogan BLM, Wills A, Heath JK and Edwards DR (1989) Developmental
expression oftissue inhibitor ofmetalloproteinase (TIMP) RNA. Development
105: 575-583
PavloffN, Staskus PW, Kishani NS and Hawkes SP (1992) A new inhibitor of
metalloproteinases from chicken: ChLMP-3. A third member ofthe TIMP
family. JBiol Chem 267: 17321-17326
Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffrey RE,
Longcoft JM, Rogers L and Stamp GWH (1992) Stromal expression of72 kDa
type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am
JPathol 141: 389-396
Pyke C, Ralfkiaer E, Tryggvason K and Dano K (1993) Messenger RNA for two
type IV collagenases is located in stromal cells in human colon cancer. Am J
Pathol 142: 359-365
Senior PV, Critchley DR, Beck F, Walker R and Varley JM (1988) The localisation
oflaminin mRNA andprotein in the postimplantation embryo andplacenta of
the mouse: an in situ hybridisation and immunochemical study. Development
104: 431-446
Stetler-Stevenson WG (1990) Type IV collagenases in tumour invasion and
metastasis. Cancer Metastasis Rev 9: 289-303
Stetler-Stevenson WG, Krutsch HC and Liotta LA (1989) Tissue inhibitor of
metalloproteinase (TIMP-2). JBiol Chem 264: 17374-17378
Uria JA, Adolfo AF, Velasco G, Freije JM and Lopez-Otin (1995) Structure and
expression in breast tumours ofhuman TIMP-3, a new member ofthe
metalloproteinase inhibitor family. Cancer Res 54: 2091-2094
Witkiewicz H, Bolander ME and Edwards DR (1993) Improved design of
riboprobes from pBluescript and related vectors for in situ hybridisation.
Biotechniques 14: 458-463
Zeng ZS, Cohen AM, Zhang ZF, Stetier-Stevenson WG and Guillem JG (1995a)
Elevated tissue inhibitor ofmetalloproteinase-1 (TIMP-1) RNA in colorectal
cancer stroma correlates with lymph node and distant metastasis. Clin Cancer
Res 1: 899-906
Zeng ZS and Guillem JG (1995b) Distinct pattems ofmatrix metalloproteinase 9 and
tissue inhibitor ofmetalloproteinase 1 mRNA expression in human colorectal
cancer and liver metastases. BrJ Cancer 72: 575-582
0ICancer Research Campaign 1997 British Joural of Cancer(1997) 75(11), 1678-1683